Summary
PJP Chart
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005.
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005.
Invesco Pharmaceuticals ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Means Investment Company Means Investment Company Inc. | 2,938 | $188,568.45 | $342,791.15 | $154,222.7 | 81.79% |
| BS Barrett Schultz Ashton Thomas Securities LLC | 55 | $4,783 | $6,417.12 | $1,634.12 | 34.17% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1,769 | $173,317.24 | $206,884.55 | $33,567.31 | 19.37% |
 Jeff Ameen Spire Wealth Management | 52 | $4,512.83 | $6,027.32 | $1,514.49 | 33.56% |
 Jeffery Yorg Focus Partners Advisor Solutions LLC | 2,077 | $217,128.8 | $243,009 | $25,880.2 | 11.92% |
Invesco Pharmaceuticals ETF (PJP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Invesco Pharmaceuticals ETF ever had a stock split?
Invesco Pharmaceuticals ETF Profile
| ARCA Exchange | US Country |
Overview
This investment vehicle is focused on the pharmaceutical sector, targeting the backbone companies of the industry in the United States. By dedicating at least 90% of its assets to securities within its underlying index, the fund ensures a high level of adherence to its core investment thesis. The underlying index itself is carefully composed of common stocks from leading pharmaceutical companies. These entities are deeply involved in critical areas such as research and development (R&D), manufacturing, and the sales or distribution of pharmaceutical and drug products. It's noteworthy that this fund opts for a non-diversified approach, emphasizing its concentrated investment in the pharma sector.
Products and Services
The fund's primary products and services revolve around its investment strategy in the pharmaceutical sector, encapsulated as follows:
- Securities Investment - The bulk of the fund's assets (at least 90%) are allocated towards securities that are part of its underlying index. This methodological approach allows for a focused investment in the pharmaceutical industry, providing investors exposure to a sector essential for health and innovation.
- Underlying Index Composition - The fund’s underlying index is a curated collection of common stocks from U.S. pharmaceutical companies highly engaged in various areas of the pharmaceutical industry. This includes intensive involvement in research and development, manufacturing, and the distribution of pharmaceuticals and drugs. This structured composition provides a solid foundation for the fund's investment premise.
